Tags

Type your tag names separated by a space and hit enter

Cholera.
Lancet. 2012 Jun 30; 379(9835):2466-2476.Lct

Abstract

Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The seventh pandemic began in 1961 and affects 3-5 million people each year, killing 120,000. Although mild cholera can be indistinguishable from other diarrhoeal illnesses, the presentation of severe cholera is distinct, with pronounced diarrhoeal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from more than 50% to less than 0·2%. Antibiotic treatment decreases volume and duration of diarrhoea by 50% and is recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programmes is being actively assessed.

Authors+Show Affiliations

Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA.Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA. Electronic address: scalderwood@partners.org.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

22748592

Citation

Harris, Jason B., et al. "Cholera." Lancet (London, England), vol. 379, no. 9835, 2012, pp. 2466-2476.
Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012;379(9835):2466-2476.
Harris, J. B., LaRocque, R. C., Qadri, F., Ryan, E. T., & Calderwood, S. B. (2012). Cholera. Lancet (London, England), 379(9835), 2466-2476. https://doi.org/10.1016/S0140-6736(12)60436-X
Harris JB, et al. Cholera. Lancet. 2012 Jun 30;379(9835):2466-2476. PubMed PMID: 22748592.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cholera. AU - Harris,Jason B, AU - LaRocque,Regina C, AU - Qadri,Firdausi, AU - Ryan,Edward T, AU - Calderwood,Stephen B, PY - 2012/7/4/entrez PY - 2012/7/4/pubmed PY - 2012/8/2/medline SP - 2466 EP - 2476 JF - Lancet (London, England) JO - Lancet VL - 379 IS - 9835 N2 - Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The seventh pandemic began in 1961 and affects 3-5 million people each year, killing 120,000. Although mild cholera can be indistinguishable from other diarrhoeal illnesses, the presentation of severe cholera is distinct, with pronounced diarrhoeal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from more than 50% to less than 0·2%. Antibiotic treatment decreases volume and duration of diarrhoea by 50% and is recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programmes is being actively assessed. SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/22748592/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(12)60436-X DB - PRIME DP - Unbound Medicine ER -